First-Ever Clinical Trial To Assess CBD As Treatment For Psychosis In Parkinson’s

King’s College London, one of the top 25 universities in the world, is teaming up with Parkinson’s UK for a £1.2-million clinical trial to determine the safety and efficacy of CBD in treating Parkinson’s-related psychosis, characterized by hallucinations and delusions.

The clinical trial will determine, for the first time, whether CBD can correct the abnormal functioning of the brain that is causing symptoms such as hallucinations and delusions.

Clinical trial in UK aims to confirm CBD as treatment for psychosis

Large clinical trial – King’s College London – seeks to affirm CBD as a treatment for psychosis..

“CBD has emerged as a promising candidate as it displays anti-anxiety and anti-psychotic like properties in animals and humans.”